Get your acronym decoders ready: Next week, the United Nations General Assembly (UNGA) and the Clinton Global Initiative (CGI) will draw leaders and policymakers—including PATH’s leaders and other innovators in global health—to New York. This week’s news included previews of the two vitally important events—CGI will focus on “mobilizing for impact,” while UNGA will tote up how far we’ve come and how far we still have to go to fulfill the Millennium Development Goals (MDGs to the cognoscenti).
Still, Devex found space for a little fun: a reveal of A-list guests at CGI. “President Barack Obama,” the usually sober site reported, “Queen Rania Al Abdullah of Jordan, former UK Prime Minister Tony Blair, Goldman Sachs’ Lloyd Blankfein, Facebook Chief Operating Officer Sheryl Sandberg, and Bono, to name a few.”
Nearing its second decade, how will the CGI evolve?
Devex Impact, September 16, 2013
[With the Clinton Global Initiative] now almost a decade old, more than a dozen global development leaders interviewed by Devex credit CGI for its special cross-sector convening power that, very early on, helped breed new partnerships for development. At the same time, because CGI maintains a business model that is unusual in the world of international development, some question if CGI should exercise more rigor to make sure that financial commitments can be traced to development outcomes.
Fast tests for drug resistance bolster malaria fight
NPR, September 11, 2013
Malaria researchers have developed what they consider a crucial advance: Simple and fast tests that can tell when parasites have become resistant to the frontline drug against malaria. . . .The tests will help scientists and health workers with several critical tasks, not possible before:
- Quickly determine if a person has a form of malaria that’s resistant to the most potent anti-malaria drug currently available.
- Map the spread of resistant malaria parasites in entire communities and regions so that control of infected mosquitoes can be focused.
- Pinpoint artemisinin-resistant malaria parasites so scientists can identify the responsible genes and develop new drugs to get ahead of resistance.
The race to improve global health
The New York Times, September 10, 2013
International health programs have greatly reduced death and sickness worldwide over the past two decades but there is still a long way to go. The United Nations General Assembly will meet later this month to assess progress—impressive in some areas, halting in others—toward achieving the United Nations’ Millennium Development Goals, which were adopted in 2000 and are supposed to be reached by the end of 2015.